Brief Summary
Type:
Lymphomas
Study Type:
Treatment
Phase:
III
ClinicalTrials.gov Identifier:
NCT06337318
Study #:
STUDY00160961
Start Date:
Oct 14, 2024
Full Details and Eligibility at clinicaltrials.gov
By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.
ClinicalTrials.gov ID: NCT06337318
View Complete Trial Details & Eligibility at ClinicalTrials.gov
